Skip to main content
OpenTrials

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,018 public trials 2,029 recruiting studies
Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Completed

Rituximab Plus Lenalidomide for Patients With Relapsed / Refractory Indolent Non-Hodgkin's Lymphoma (Follicular Lymphoma and Marginal Zone Lymphoma)

NCT01938001

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +6 more
Locations
  • Mitchell Cancer Center, University of South Alabama Mobile, Alabama, United States
  • Arizona Center for Cancer Care Glendale, Arizona, United States
  • Southwest Cancer Care Medical Group Escondido, California, United States
  • Marin Oncology Associates Greenbrae, California, United States
View all 160 locations
View Trial Details
Completed

A Study Evaluating the Impact of Venetoclax on the Quality of Life for Subjects With Relapsed (Your Cancer Has Come Back) or Refractory (no Response to Previous Cancer Treatments) Chronic Lymphocytic Leukemia (CLL) While Receiving Venetoclax Monotherapy (a Single Agent).

NCT02980731

Conditions
Chromosome 17 deletion, Chronic Disease, Chronic Lymphocytic Leukemia (CLL), +15 more
Locations
  • Hospital Italiano La Plata /ID# 150812 La Plata, Buenos Aires, Argentina
  • Fundaleu /Id# 150811 Ciudad Autonoma de Buenos Aire, Ciuadad Autonoma de Buenos Aires, Argentina
  • Cemic /Id# 150810 Ciudad Autonoma de Buenos Aire, Ciuadad Autonoma de Buenos Aires, Argentina
  • Sanatorio Allende /ID# 150813 Córdoba, Argentina
View all 33 locations
View Trial Details
Completed

A Study of KRN125 in Patients With Multiple Myeloma and Malignant Lymphoma

NCT05007652

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +15 more
Locations
  • Nagoya City University Hospital Nagoya, Aichi-ken, Japan
  • The Jikei University Kashiwa Hospital Kashiwa, Chiba, Japan
  • Hospital of the University of Occupational and Environmental Health Kitakyushu, Fukuoka, Japan
  • Hokkaido University Hospital of the National University Corporation Sapporo, Hokkaido, Japan
View all 21 locations
View Trial Details
Completed

Treosulfan, Fludarabine Phosphate, and Total-Body Irradiation in Treating Patients With Hematological Cancer Who Are Undergoing Umbilical Cord Blood Transplant

NCT00796068

Conditions
Acute Biphenotypic Leukemia, Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia in Remission, +25 more
Locations
  • University of Colorado Hospital Aurora, Colorado, United States
  • Oregon Health and Science University Portland, Oregon, United States
  • Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
View Trial Details

Related conditions